Skip to main content

The LSE Health Working Paper Series in Health Policy and Economics

The LSE Health working paper series publishes high quality research papers, which reflect the range and diversity of theoretical and empirical work relating to health policy and economics.

WP46
The Blow of Domestic Violence on Children's Health Outcomes Mireia Jofre-Bonet, Melcior Rossello-Roig and Victoria Serra-Sastre

WP45
A Comparative Analysis of the Regulatory Requirements of Orphan Medicinal Products in the United States and European Union Emilie Taymor and Panos Kanavos

WP44
Comparisons of Health Technology Assessment Appraisal Outcomes and Methodologies in Oncology Indications across Four Countries Nick Petersdorf and Panos Kanavos

WP43
Health Technology Assessment of Cancer Drugs in France and Germany - Commonalities and Differences in the Value Assessment of Medical Technologies Anna Szerb and Panos Kanavos

WP42
An analysis of HTA decisions for orphan drugs in Canada and Australia Caroline Solon and Panos Kanavos

WP41
Treating schizophrenia during pregnancy: A systematic literature review on the impact of drug treatment on mother and foetus Mari Grepstad, Victoria Tzouma, Federico Grimaccia and Panos Kanavos

WP40
Treating rheumatoid arthritis during pregnancy: A systematic literature review of the impact of drug treatment on mother and foetus Victoria Tzouma, Mari Grepstad and Panos Kanavos

WP39
Treating epilepsy during pregnancy: a systematic literature review of the impact of drug treatment on mother and foetus Federico Grimaccia and Panos Kanavos

WP38
Assessing Long-Term Care Partnerships: An Old Concept to Redefine? Savannah Bergquist, Joan Costa-Font and Katherine Swartz

WP37
Long Term Care Coverage in Europe: A Case for 'Implicit Insurance Partnerships' Joan Costa-i-Font and Valentina Zigante

WP36
Policy Dilemmas in Financing Long-term Care in Europe Joan Costa-i-Font, Christophe Courbage and Peter Zweifel

WP35
Analysis of prices paid by low-income countries - how price sensitive is government demand for medicines? Divya Srivastava and Alistair McGuire

WP34
Using MCDA to assess value of new medical technologies Aris Angelis and Panos Kanavos

WP33
Multiple Criteria Decision Analysis for Value Based Assessment of New Medical Technologies: A Conceptual Framework Panos Kanavos and Aris Angelis

WP32
Inequalities in Self-Reported Health: A Meta-Regression Analysis Joan Costa-i-Font and Cristina Hernández-Quevedo

WP31
Globesity: Is Globalization a Pathway to Obesity? Joan Costa-i-Font, Núria Mas and Patricia Navarro

WP30
Intergenerational and Socioeconomic Gradients of Child Obesity Joan Costa-i-Font and Joan Gil

WP29
Do Income Gradients in Unhealthy Behaviours Explain Patterns of Health Inequalities? Joan Costa-i-Font, Cristina Hernández-Quevedo and Dolores Jiménez-Rubio

WP28
The hedonic placebo effect of traditional medicines Azusa Sato and Joan Costa-i-Font

WP27
Does culture matter at all in explaining why people still use traditional medicines? Azusa Sato and Joan Costa-i-Font

WP26
Are Health Care 'Choice - and - Competition' Reforms really Efficiency Driven? Joan Costa-i-Font and Valentina Zigante

WP25
Publication Selection in Health Policy Research: the Winner's Curse Hypothesis Joan Costa-i-Font, Alistair McGuire and Tom Stanley

WP24
Pathways towards chronic-care focused healthcare systems: evidence from Spain
Manuel García-Goñi, Cristina Hernández-Quevedo, Roberto Nuño-Solinís and Francesco Paolucci

WP23
Demand and Pricing of Preventative Health Care Sotiris Vandoros and Katherine Grace Carman

WP22
Using a Vector Autoregression Framework to measure the quality of English NHS hospitals Irene Papanicolas and Alistair McGuire

WP21
Using a latent variable approach to measure the quality of English NHS hospitals Irene Papanicolas and Alistair McGuire

For more information about the series, contact the LSE Health communications team.